Author

Christoph Ullmer

F. Hoffmann-La Roche AGORCID 0000-0002-1044-6722Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Andrea ChiccaiD· 1 shared Antonello CarusoiD· 1 shared Daniel BátoraiD· 1 shared Jürg GertschiD· 1 shared Jürgen FingerleiD· 1 shared Matthias MülleriD· 1 shared Pál PacheriD· 1 shared Roland Degen· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andrea ChiccaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies

Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Härtung, Roland Degen, Matthias Müller, Uwe Grether, Pál Pacher, Jürg Gertsch

This paper develops and characterizes RNB-61, a potent and selective CB2R agonist with favorable pharmacokinetics, showing nephroprotective effects in kidney injury models.

ACS Pharmacology & Translational Science · Jul 9, 2024Peer-reviewedPharmacology & Toxicology